USEUROPEAFRICAASIA 中文雙語Fran?ais
    China
    Home / China / China

    Interest in TCM growing globally

    By Shan Juan | China Daily | Updated: 2013-03-27 07:14

    Chinese mainland accounts for 2% of herbal medicine sales worldwide

    While some Chinese scholars propose abolishing traditional Chinese medicine, foreign pharmaceutical institutions and industries are pursuing them.

    More than 100 countries and regions around the world have set up TCM institutions, with the United States, Europe, Japan and South Korea investing heavily in related research and medication development, industry, analyses show.

    The UK-based pharmaceutical company GlaxoSmithKline PLC announced its first TCM medication research and development program, which targets not just the Chinese market, but the global one as well.

    "TCM is a well-established medical science based on thousands of years of clinical practices. It shows great promise treating complicated conditions that the single-target Western medicine has failed to handle," said Zang Jingwu, senior vice-president and head of GlaxoSmithKline's R&D in China.

    "Our priority is to transform TCM from an experience-based practice to evidence-based medicines through innovation and differentiation," he said.

    Currently, a 10-person team in Shanghai is in charge of the program, with a medication candidate for skin disease in the works.

    Zang, a US-trained neurologist, said TCM is more of a multi-target therapeutical approach, which might work to treat complex conditions.

    He said an example of this is ginkgo biloba leaf extract, approved in Germany, which, according to China's pharmacopeia, is TCM in essence. Globally, ginkgo biloba leaf extract is widely used to treat dizziness and ringing in the ears.

    Industry insiders call such products "exotic TCM". In ancient TCM works, ginkgo is known for restoring consciousness.

    "That is similar to our approach in TCM R&D," he said. He referred to skin diseases for which medications can demonstrate more evidence of effectiveness as a top candidate for TCM. Other areas of research that also show great promise include stomach and intestinal diseases and supplementary treatments for cancer, he added.

    However, given that the culture and ideology of TCM is different from that of Western medicine, great innovation is required to integrate the two sciences, he said.

    "In fact, many in Western medicine circles have recognized the importance of TCM, but the problem is how to prove and develop that," said Huang Jianyin, deputy secretary-general of the World Federation of Chinese Medicine Societies.

    TCM is developed through empirical testing and refinement of herbal mixtures and relies on clinical experience, and many in the West don't trust that, he said. TCM, particularly herbal products, are largely available in the US and Europe, but questions like how to prove their effectiveness in the context of Western medicine and how to best use them remain unanswered, Zang added.

    Zhang Lingping, director of the international cooperation department of the Beijing University of Chinese Medicine, welcomed the emerging trend.

    "Their increasing interest shows Western medicine circles have begun to learn about the time-honored medical science, which originated in China," she said. Zhang said traditionally, Western medicines have been highly targeted and such a method doesn't seem to work well for complex diseases.

    "They are beginning to closely look at TCM, which highlights a natural and comprehensive manner in healing," she said.

    The university also had partnerships with foreign academic institutions in TCM research focusing on cancer and cardio-cerebrovascular diseases.

    A better approach for TCM development is to enhance its dosage and stability, she said.

    "It's more feasible and practical for them to improve the techniques during the TCM production, which the multinational pharmaceutical giants are better at," she said.

    But that might also pose a challenge for domestic TCM industries, she acknowledged.

    Of the global herbal medicine sales volume, the Chinese mainland accounted for only 2 percent, industry analyses show. Japan has the share of the market at 90 percent.

    Mao Zedong once expected TCM and Chinese cuisine would be China's two major contributions to the world, said Huang. "He wouldn't have imagined the tough situation today."

    shanjuan@chinadaily.com.cn

    Editor's picks
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    国产成人亚洲综合无码| 亚洲国产午夜中文字幕精品黄网站| 最近2019年中文字幕一页| 精品一区二区三区无码免费视频| 五月天中文字幕mv在线女婷婷五月 | 无码人妻熟妇AV又粗又大 | 久久青青草原亚洲av无码app| 久久伊人中文无码| 国产精品 中文字幕 亚洲 欧美 | 人妻丰满熟妇aⅴ无码| 天堂亚洲国产中文在线 | A∨变态另类天堂无码专区| 日韩AV片无码一区二区三区不卡| 亚洲中文久久精品无码| 国产日韩精品无码区免费专区国产| 亚洲av中文无码乱人伦在线r▽ | 久久久久亚洲AV无码去区首| 无码永久免费AV网站| 合区精品久久久中文字幕一区 | 97人妻无码一区二区精品免费| 中文字幕乱偷无码AV先锋| 中文字幕亚洲一区| 久久精品中文字幕第23页| 亚洲中文字幕无码中文字在线| 中文字幕理伦午夜福利片| 无码丰满熟妇一区二区| 国产日产欧洲无码视频无遮挡| 91精品日韩人妻无码久久不卡 | 久久久久亚洲av成人无码电影| 国产精品无码无片在线观看| 无码精品一区二区三区在线| 无码人妻少妇久久中文字幕蜜桃 | 亚洲av永久无码精品网站| 中文字幕精品无码一区二区三区 | 无码AV天堂一区二区三区| 亚洲大尺度无码专区尤物| 亚洲欧洲无码AV电影在线观看| 亚洲国产一二三精品无码| 亚洲精品成人无码中文毛片不卡| 亚洲AV无码专区电影在线观看| 亚洲AV无码成人专区片在线观看|